Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
OPTAVIA's clinical program reduces visceral fat 14% and retains 98% lean mass, directly addressing the metabolic impact of perimenopause and menopause.
-
OPTAVIA's RCT used DXA scanning and a 92.3% completion rate to document 98% lean mass retained in 198 participants across 16 weeks.
-
Peer-reviewed research is redefining weight loss program standards, with OPTAVIA's RCT showing 98% lean mass preservation over 16 weeks.
-
Peer-reviewed research shows OPTAVIA's structured meal replacement program reduces visceral fat 14% and preserves 98% lean mass over 16 weeks.
-
The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
-
SAN DIEGO, CA--(Marketwired - Jan 9, 2014) - Internet Marketing Inc. (IMI), the fastest growing full service integrated digital marketing agency in the country recently added Medifast Weight...